Copyright
©The Author(s) 2017.
World J Med Genet. Feb 27, 2017; 7(1): 1-9
Published online Feb 27, 2017. doi: 10.5496/wjmg.v7.i1.1
Published online Feb 27, 2017. doi: 10.5496/wjmg.v7.i1.1
Feature | Classic approach | NGS approach |
Analytical requirements for a full characterization of the CFTR gene | Multiple technical steps and different analytical platforms | Reduced number of technical steps and single analytical platform |
Data elaboration | Multiple data elaboration steps handled by the laboratory itself | Reduced number of data elaboration steps often performed by internal dedicated personnel or external structures |
Throughput | Low | High |
Automation | Moderate | High |
Timing | Time consuming | Rapid |
Cost per sample | High | Low (if a reasonably high number of samples are processed in the same run) |
No. of mutations analyzed | Progressively increasing from moderate (first steps) to high (last steps) | High |
Detection rate | Progressively increasing from moderate (first steps) to high (last steps) | High |
Possibility to analyze other genes involved in the modulation of CF clinical manifestations | Unlikely | Realistic |
Feature | Classic approach | NGS approach |
- Citation: Lucarelli M. New era of cystic fibrosis: Full mutational analysis and personalized therapy. World J Med Genet 2017; 7(1): 1-9
- URL: https://www.wjgnet.com/2220-3184/full/v7/i1/1.htm
- DOI: https://dx.doi.org/10.5496/wjmg.v7.i1.1